• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

3,5,3'-三碘甲状腺原氨酸对DNA拓扑异构酶I的多聚(ADP-核糖基)化的体外作用

In vitro effect of 3,5,3'-triiodothyronine on poly(ADP-ribosyl)ation of DNA topoisomerase I.

作者信息

Giannoni P, Scarabelli L, Orunesu M, Cesarone C F

机构信息

Istituto di Fisiologia Generale, Università di Genova.

出版信息

Ital J Biochem. 1995 May-Jun;44(3):129-36.

PMID:7591671
Abstract

DNA topoisomerase I activity (topo I) is known to be inhibited by poly(ADP-ribosyl)ation. Both poly(ADP-ribose)polymerase (pADPRP) and DNA topoisomerase I participate to major biological events, such as DNA transcription, repair and synthesis. It has been shown that thyroid hormones, such as 3,5,3'-triiodothyronine (T3), stimulate DNA transcription and down-regulate pADPRP activity. Using an in vitro model, we have studied the poly(ADP-ribosyl)ation of topo I, in vitro, in the presence of T3. T3 treatment of pADPRP inhibits the enzyme up to 75-80% of control activity. DNA topoisomerase I relaxing activity was determined on supercoiled plasmid DNA, and topoisomers were separated by agarose gel electrophoresis. Poly(ADP-ribosyl)ation completely inhibits the relaxing activity of topo I, with respect to non-ribosylated controls, but the activity remains unaffected when pADPRP is inactivated by heat or treated with specific inhibitors, such as 3-aminobenzamide (3ABA). In this study we show that treatment of pADPRP with T3 reduces the inhibition on topo I. In this system 10(-8) M T3 was effective in maintaining almost all topo I activity, even though modifications in processivity and distributivity of the reaction were noted. These data support a close relationship between pADPRP and topo I in hormone-stimulated DNA transcription.

摘要

已知DNA拓扑异构酶I活性(拓扑异构酶I)会受到聚(ADP - 核糖基)化的抑制。聚(ADP - 核糖)聚合酶(pADPRP)和DNA拓扑异构酶I都参与了诸如DNA转录、修复和合成等重大生物学事件。研究表明,甲状腺激素,如3,5,3'-三碘甲状腺原氨酸(T3),可刺激DNA转录并下调pADPRP活性。我们使用体外模型,研究了在T3存在下体外拓扑异构酶I的聚(ADP - 核糖基)化情况。用T3处理pADPRP可使该酶活性抑制至对照活性的75 - 80%。在超螺旋质粒DNA上测定DNA拓扑异构酶I的解旋活性,通过琼脂糖凝胶电泳分离拓扑异构体。与未进行核糖基化的对照相比,聚(ADP - 核糖基)化完全抑制了拓扑异构酶I的解旋活性,但当pADPRP经加热失活或用特定抑制剂如3 - 氨基苯甲酰胺(3ABA)处理时,该活性不受影响。在本研究中,我们表明用T3处理pADPRP可减少对拓扑异构酶I的抑制。在该系统中,10^(-8) M的T3能够有效维持几乎所有拓扑异构酶I的活性,尽管观察到反应的持续合成能力和分布能力有所改变。这些数据支持了在激素刺激的DNA转录过程中pADPRP与拓扑异构酶I之间存在密切关系。

相似文献

1
In vitro effect of 3,5,3'-triiodothyronine on poly(ADP-ribosyl)ation of DNA topoisomerase I.3,5,3'-三碘甲状腺原氨酸对DNA拓扑异构酶I的多聚(ADP-核糖基)化的体外作用
Ital J Biochem. 1995 May-Jun;44(3):129-36.
2
DNA topoisomerase I activity in regenerating liver of hypothyroid rats.
Boll Soc Ital Biol Sper. 1998 Jan-Feb;74(1-2):9-14.
3
Some electron microscopic aspects of poly(ADPR) polymerase-DNA interactions and of auto-poly(ADP-ribosyl)ation reaction.聚(ADP-核糖)聚合酶与DNA相互作用及自身聚(ADP-核糖基)化反应的一些电子显微镜观察方面
Princess Takamatsu Symp. 1983;13:71-81.
4
Purification and properties of poly(ADP-ribose)polymerase from Crithidia fasciculata. Automodification and poly(ADP-ribosyl)ation of DNA topoisomerase I.来自克氏锥虫的聚(ADP-核糖)聚合酶的纯化及性质。DNA拓扑异构酶I的自身修饰和聚(ADP-核糖基)化作用。
Mol Biochem Parasitol. 2004 Jun;135(2):211-9. doi: 10.1016/j.molbiopara.2004.02.005.
5
Regulation of the expression or recruitment of components of the DNA synthesome by poly(ADP-ribose) polymerase.聚(ADP - 核糖)聚合酶对DNA合成体组分的表达或募集的调控。
Biochemistry. 1998 Jun 30;37(26):9363-70. doi: 10.1021/bi9731089.
6
A novel function of poly(ADP-ribosyl)ation: silencing of RNA polymerase II-dependent transcription.聚(ADP-核糖基)化的一种新功能:RNA聚合酶II依赖性转录的沉默。
Biochemistry. 1998 Feb 10;37(6):1465-9. doi: 10.1021/bi9727390.
7
FGF2-mediated upregulation of urokinase-type plasminogen activator expression requires a MAP-kinase dependent activation of poly(ADP-ribose) polymerase.成纤维细胞生长因子2介导的尿激酶型纤溶酶原激活剂表达上调需要丝裂原活化蛋白激酶依赖的聚(ADP-核糖)聚合酶激活。
J Cell Physiol. 2005 Jan;202(1):125-34. doi: 10.1002/jcp.20096.
8
Bcl-2 prevents topoisomerase II inhibitor GL331-induced apoptosis is mediated by down-regulation of poly(ADP-ribose)polymerase activity.Bcl-2可防止拓扑异构酶II抑制剂GL331诱导的细胞凋亡,这是由聚(ADP-核糖)聚合酶活性的下调介导的。
Oncogene. 1998 Oct 29;17(17):2225-34. doi: 10.1038/sj.onc.1202133.
9
Chromatin architecture and functions: the role(s) of poly(ADP-RIBOSE) polymerase and poly(ADPribosyl)ation of nuclear proteins.染色质结构与功能:聚(ADP - 核糖)聚合酶及核蛋白聚(ADP核糖基)化的作用
Biochem Cell Biol. 2005 Jun;83(3):396-404. doi: 10.1139/o05-042.
10
Effect of simulated microgravity conditions on poly(ADP-ribose) polymerase activity in primary cultures of adult rat hepatocytes.模拟微重力条件对成年大鼠原代肝细胞培养物中聚(ADP - 核糖)聚合酶活性的影响。
J Gravit Physiol. 2001 Jul;8(1):P127-8.

引用本文的文献

1
Natural inhibitors of poly(ADP-ribose) polymerase-1.聚(ADP-核糖)聚合酶-1 的天然抑制剂。
Mol Neurobiol. 2012 Aug;46(1):55-63. doi: 10.1007/s12035-012-8257-x. Epub 2012 Apr 4.
2
Novel modulators of poly(ADP-ribose) polymerase.聚(ADP - 核糖)聚合酶的新型调节剂
Trends Pharmacol Sci. 2006 Dec;27(12):626-30. doi: 10.1016/j.tips.2006.10.003. Epub 2006 Oct 19.
3
Apoptosis in the heart: when and why?心脏中的细胞凋亡:何时以及为何发生?
Mol Cell Biochem. 1996 Oct-Nov;163-164:261-75. doi: 10.1007/BF00408667.